Fiera Capital Corp Trims Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Fiera Capital Corp reduced its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.7% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,774,123 shares of the healthcare conglomerate’s stock after selling 31,156 shares during the period. UnitedHealth Group comprises approximately 3.1% of Fiera Capital Corp’s portfolio, making the stock its 7th biggest holding. Fiera Capital Corp owned about 0.19% of UnitedHealth Group worth $1,037,294,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in UNH. China Universal Asset Management Co. Ltd. grew its stake in shares of UnitedHealth Group by 20.6% during the first quarter. China Universal Asset Management Co. Ltd. now owns 10,867 shares of the healthcare conglomerate’s stock valued at $5,376,000 after buying an additional 1,857 shares during the last quarter. Quent Capital LLC grew its stake in shares of UnitedHealth Group by 5.5% during the first quarter. Quent Capital LLC now owns 4,196 shares of the healthcare conglomerate’s stock valued at $2,076,000 after buying an additional 217 shares during the last quarter. Nelson Capital Management LLC grew its stake in shares of UnitedHealth Group by 3.1% during the first quarter. Nelson Capital Management LLC now owns 12,844 shares of the healthcare conglomerate’s stock valued at $6,354,000 after buying an additional 387 shares during the last quarter. Allen Investment Management LLC grew its stake in shares of UnitedHealth Group by 4.9% during the first quarter. Allen Investment Management LLC now owns 857,397 shares of the healthcare conglomerate’s stock valued at $424,154,000 after buying an additional 40,291 shares during the last quarter. Finally, Capital Wealth Planning LLC grew its stake in shares of UnitedHealth Group by 8.0% in the first quarter. Capital Wealth Planning LLC now owns 977,239 shares of the healthcare conglomerate’s stock worth $483,440,000 after purchasing an additional 72,068 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the stock. KeyCorp started coverage on shares of UnitedHealth Group in a report on Friday, October 11th. They set an “overweight” rating and a $675.00 target price for the company. Hsbc Global Res downgraded UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Thursday, October 17th. Robert W. Baird upped their price target on UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 17th. Bank of America decreased their price objective on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. Finally, Truist Financial reiterated a “buy” rating and issued a $625.00 target price (down previously from $640.00) on shares of UnitedHealth Group in a research note on Wednesday, October 16th. Four equities research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $615.53.

UnitedHealth Group Trading Up 1.6 %

UnitedHealth Group stock traded up $9.97 during trading on Friday, hitting $615.42. The company’s stock had a trading volume of 993,978 shares, compared to its average volume of 3,892,864. The stock’s fifty day moving average is $581.13 and its 200 day moving average is $543.74. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $617.44. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.88 and a current ratio of 0.91. The stock has a market capitalization of $566.36 billion, a price-to-earnings ratio of 40.01, a P/E/G ratio of 1.75 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. UnitedHealth Group’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $6.56 earnings per share. As a group, equities research analysts predict that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be issued a dividend of $2.10 per share. The ex-dividend date is Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.36%. UnitedHealth Group’s dividend payout ratio is 54.72%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.